GeneFab

GeneFab

Cell and gene therapy CDMO for clinical to commercial supply

Overview

GeneFab is a contract development and manufacturing organization for cell and gene therapies, running cGMP facilities in Alameda, California that support programs from genetic design through commercial supply. The company manufactures ex vivo cell therapies such as CAR-T, TCR-T, CAR-NK, Treg, and iPSC products, plus in vivo lentiviral vector gene therapies at suspension scales up to 200 liters, backed by synthetic biology, process development, analytics, and cell banking. What sets GeneFab apart is its co-development approach, pairing partners with staff who worked on the innovator side and integrating every function under one roof with real-time transparency. The goal is to remove the obstacles between promising science and the patients who need it.

About GeneFab

Simplify's Rating
Why GeneFab is rated
B-
Rated B on Competitive Edge
Rated B on Growth Potential
Rated C on Differentiation

Industries

Industrial & Manufacturing

Biotechnology

Healthcare

Company Size

N/A

Company Stage

N/A

Total Funding

N/A

Headquarters

N/A

Founded

N/A

Simplify Jobs

Simplify's Take

What believers are saying

  • RegCell partnership expands U.S. clinical manufacturing for autoimmune Treg therapies.
  • GeneFab's May 2026 facility launch adds capacity for new customers immediately.
  • Cell-specific control products create higher-margin attach opportunities across future gene therapy programs.

What critics are saying

  • Bigger CDMOs like Thermo Fisher and Lonza pressure margins and win late-stage programs.
  • RegCell dependence exposes GeneFab if autoimmune Treg timelines slip beyond 2025.
  • If Alameda expansion and product adoption lag, GeneFab burns cash and stalls operations.

What makes GeneFab unique

  • GeneFab combines synbio design, CRDMO services, and GMP manufacturing in Alameda.
  • On May 4, 2026, GeneFab launched pre-validated promoters and drug-induced switches.
  • Its Alameda site offers seven GMP clean rooms and parallel manufacturing wings.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

401(k) Retirement Plan

Flexible Work Hours

Hybrid Work Options

Remote Work Options

Paid Vacation

Paid Sick Leave

Paid Holidays

Paternity Leave

Maternity Leave

Professional Development Budget

Conference Attendance Budget

Wellness Program

Mental Health Support

Phone/Internet Stipend

Home Office Stipend

Stock Options

Company Equity

Family Planning Benefits

Fertility Treatment Support

Adoption Assistance

Parental Leave

Relocation Assistance

Meal Benefits

Employee Referral Bonus

Tuition Reimbursement

Legal Services

Childcare Support

Elder Care Support

Gym Membership

Commuter Benefits

Performance Bonus

Profit Sharing

Employee Stock Purchase Plan

Training Programs

Tuition Reimbursement

Company News

Contract Pharma
May 7th, 2025
GeneFab & RegCell Partner for Treg Therapy Manufacturing in the U.S.

GeneFab, a cell and gene therapy-focused contract research, development, and manufacturing organization (CRDMO), has partnered with RegCell, a biotech company advancing regulatory T cell (Treg) therapies for autoimmune diseases, to support the tech transfer and clinical manufacturing of RegCell's Treg platform as it transitions from Japan to GeneFab's manufacturing facility in Alameda.

Recently Posted Jobs

Sign up to get curated job recommendations

GeneFab is Hiring for 8 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify. Browse all jobs →